References
- Baekeland F., Lund wall L. Dropping out of treatment: A critical review. Psychol. Bull. 1975; 82: 738–783
- Ginzberg H. M. Naltrexone: Its Clinical Utility. U.S. Government Printing Office, Washington, DC 1984, (NIDA Treatment Research Report No. (ADM) 84–1358)
- Lowinson J. H. Methadone maintenance in perspective. Substance Abuse: Clinical Problems and Perspectives, J. H. Lowinson, P. Ruiz. Williams and Wilkins, Baltimore 1981
- McLellan A. T., Luborsky L., O'Brien C. P., Woody G. E., Druley K. A. Is treatment for substance abuse effective?. J. Am. Med. Asoc. 1982; 247: 1423–1428
- McLellan A. T., Luborsky L., Woody G. E., O'Brien C. P. An improved diagnostic instrument for substance abuse patients. J. Nerv. Ment. Dis. 1980; 168: 26–33
- O'Brien C. P., Greenstein R. A. Treatment approaches: Opiate antagonists. Substance Abuse: Clinical Problems and Perspectives, J. H. Lowinson, P. Ruiz. Williams and Wilkins, Baltimore 1981; 403–407
- Parwatikar S., Crawford J., Nelkupa J. V., DeGracia C. Factors influencing success in an antagonistic treatment program. Narcotic Antagonists: Naltrexone, J. Demetrious, P. Renault. U.S. Government Printing Office, Washington, DC 1976; 77–81, (NIDA Research Monograph No. 9)
- Resnick R. B., Washton A. M. Clinical outcome with naltrexone. Ann. N. Y. Acad. Sci. 1978; 311: 241–247
- Woody G. E., O'Brien C. P., McLellan A. T., Mintz J. Psychotherapy for opiate addiction: Some preliminary results. Ann. N. Y. Acad. Sci. 1981; 362: 91–100